Search Results 31-40 of 79 for USDT场外交易【电报：@heimifeng8】正规平台安全有保障

  1. Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma - Mayo Clinic

    About this study. This partially randomized phase I/II trial studies the side effects and best dose of sapanisertib and to see how well it works compared to ...

  2. Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. CAST-AI: Cystectomy after systemic therapy with ADC and Immunotherapy - Mayo Clinic

    The purpose of this study is to evaluate progression-free survival at 12 months in patients undergoing treatment with EV/Pembro and CC/U with or without MDT.

  4. https://www.mayoclinic.org/chinese_condition_consolidated_concepts.xml

  5. A Study to Evaluate Docetaxel With or Without Bintrafusp Alfa to Treat Patients with Advanced Non-small Cell Lung Cancer - Mayo Clinic

    The purpose of this study is to compare the progression-free survival (PFS) of docetaxel in combination with bintrafusp alfa vs. docetaxel alone. Participation ...

  6. A Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients With Advanced or Metastatic Renal Cell Carcinoma - Mayo Clinic

    About this study. Phase 1b: To evaluate safety and tolerability and determine a recommended phase 2 dose for TRC105 when added to standard dose axitinib in ...

  7. https://www.mayoclinic.org/arabic_condition_consolidated_concepts.xml

  8. A Study for Subjects Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. https://www.mayoclinic.org/spanish_condition_consolidated_concepts.xml

  10. Study of ASTX727 vs IV Decitabine in MDS and CMML - Mayo Clinic

    After completion of PK studies during the first 2 treatment cycles, subjects will continue to receive treatment with ASTX727 from Cycle 3 onward (in 28-day ...